Osteoporosis Medications (Non-Bisphosphonates)

Non-Bisphosphonates Facts and Risks

The following are side effects of the non-bisphosphonate drugs on the market. The two drugs listed here are the most commonly prescribed in this category, but others are currently in development, and could potentially be released soon.

Raloxifene (Evista) is an osteoporosis medication. The following is the list of side effects found on the FDA website for EVISTA, as well as the manufacturer’s website for EVISTA:

Source: Evista Medication Guide, 2011. ID: Eli Lilly and Company

http://www.evista.com/Pages/starting-evista.aspx

 

Teriparatide (Forteo) is typically prescribed for more severe osteoporosis, and individuals who have already had osteoporotic fractures. The following is the list of its side effects found on the FDA website:

Source: Forteo Medication Guide, 2011. ID: Eli Lilly and Company

http://www.forteo.com/Pages/index.aspx?WT.srch=1

 

Enhanced by Zemanta